Showing results (461-470 of 1,333) with videos related to
Sort By:
Pageof 134
Blood Cells, Molecules & Diseases|January 1, 1995
The clinical course of treated and untreated Gaucher disease. A study of 45 patientsE Beutler, A Demina, K Laubscher, et al.Blood|July 1, 1992
New glucose-6-phosphate dehydrogenase mutations from various ethnic groupsE Beutler, B Westwood, J T Prchal, et al.The Turkish Journal of Pediatrics|February 24, 2001
Triosephosphate isomerase deficiency with elevated sweat chloride test: report of a caseI Yenicesu, O Kalayci, E Semizel, et al.Blood|September 1, 1991
Enzyme replacement therapy for Gaucher diseaseE Beutler, A Kay, A Saven, et al.Blood|October 9, 1998
The relationship of the -5, -8, and -24 variant alleles in African Americans to triosephosphate isomerase (TPI) enzyme activity and to TPI deficiencyA Schneider, L Forman, B Westwood, et al.Proceedings of the National Academy of Sciences of the United States of America|February 20, 1996
The treatment of chronic progressive multiple sclerosis with cladribineE Beutler, J C Sipe, J S Romine, et al.Blood|January 1, 1995
Glucose-6 phosphate dehydrogenase mutations and haplotypes in various ethnic groupsW Xu, B Westwood, C S Bartsocas, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|July 1, 1996
Development of cladribine treatment in multiple sclerosisJ C Sipe, J S Romine, J A Koziol, et al.Thrombosis and Haemostasis|October 18, 1993
Inhibition of endothelial cell expression of plasminogen activator inhibitor type-1 by gemfibrozilS Fujii, H Sawa, B E SobelJapanese Heart Journal|January 1, 1996
Persistence of balloon-induced arterial injury with hyperlipidemia despite gemfibrozilC Lundgren, B E Sobel, S FujiiPageof 134